The #IAPYPL are delighted to welcome you to our global event at the #WHS2022 and hear the 21 outstanding leaders below 40. The event harnesses leading minds to advance sound policies. It is tomorrow- 18th CEST 11am-1230pm worldhealthsummit.zoom.us/j/84849331333
Young physician leadership for United Kingdom, me to safeguard #immunocompromised
Young physician leadership for Phillippines- healthcare integration and leadership
Young physician leadership for Sri Lanka- Solutions for neglected conditions
Young physician leadership for S. Korea- Becoming change agents
Young physician leadership for United States- transnational infrastructure
Young physician leadership for India- Access to technology and diversity
Young physician leadership for Sri Lanka- accessible technology
This will be a very exciting event as we are hearing insights from across the globe. Thanks to the @IAPartnership for bringing us together for this global event in Berlin. Tomorrow- 18th CEST 11am-1230pm worldhealthsummit.zoom.us/j/84849331333
1/x *** New Research ***. 😀What can be done to protect immunocompromised patients? New press release from @AstraZeneca. , and it's about a therapy called Sipavibart, the successor to Evusheld. astrazeneca.com/media-centre/p…
2/x. What is the background? Some individuals in our community are more prone to infections, they are called immunocomromised. There are ~ 500,000-1.5M with these conditions. When they get infections, they can fight it less well. 🙄 And the pandemic hit, this was a problem.
3/x It includes renal transplant patients, primary immunodeficiencies, those with cancer & blood cancers, kidney disease, and those with primary immunodeficiencies. It's a fair number. Most doctors want to protect these patients from infectious diseases by what ever means 😇
1/x 🧵 ***NEW RESEARCH *** How has #COVID-19 disease evolved in people living with #cancer and who remains at risk? Find out more in our latest publication from @UKCORONACANCER: https://t.co/P9NdBtbCRWnature.com/articles/s4159…
2/x It is relevant as healthcare systems develop strategies for living with SARS-CoV-2 as an endemic disease and informing individual discussions between cancer patients and their oncologists. And to ensure that no one is left behind or forgotten.
3/x What was done? They analysed COVID-19 infections in the 🏴 population, assessing rates of COVID-19 related hospitalisation, intensive care admission and mortality. It ran Winter 20-Summer 22
2/x What's the issue ? The UK delivers successful cancer care. Year on year, people live longer and better lives. gov.uk/government/new…. 10% improved survival in 15 years. That is by achieved early diagnosis, having better treatment the best cancer staff, research. 😀🏆🇬🇧✊
3/x but.... there's a flipside. Our Cancer leadership quote "Demand for cancer treatment is increasing by approximately 6-8% every year" and "They are being asked to deliver more treatment with the same staffing numbers"
1/x 🧵This Friday at 10:30am, we're excited to announce the reboot of the #forgotten500K campaign with an update from the podcasts hosted by @claremenglish, @MarkOak04974342, @NikolaBrigden. Here's the message for 2023 in advance. RT. 👇
2/x "The #forgotten500K are a group of immunocompromised patients who have not been prioritized during the pandemic and are experiencing higher ongoing levels of risk. The group started off as individuals asking for help while still in isolation during the pandemic.
3/x They were speaking as individuals trying their best to be heard virtually, as they were not able to leave their homes and re-enter normal life like everyone else. However, the #forgotten500K patient campaign brought them together, providing support and one voice. amazing
1/x Several months ago, @katebingham2 drove the UK pandemic response. She is incredible 🦸♀️- thanks for your insight. But then she finished and something extraordinary happened. The Winter plan to protect the #immunocompromised was quietly dropped....😫 Why does it matter? 🤷🤷♂️🤷♀️
2/x Because it had widespread clinical & academic backing for our 2022 Winter plan. Cohorts were identified & large teams of clinicians worked around the clock to work out which of #immunocompromised who don't have high levels of protection from vaccination could be protected 👩⚕️
3/x This would have put us in line with 32 countries who were protected their #immunocompromised during the Winter months when COVID cases rise. If you don't respond to vaccines 💉, then your risk of hospitalisation, ITU admission & not recovering from COVID is 📈
2/x Why did they do it? Because 1⃣ cancer patients are at high risk from covid 📈 2⃣ Many don't get an immune response to vaccines 💉 3⃣ They wanted to find the scale of the problem 💥. So they decided to go global! 🌐
3/x. The team searched 3065 papers published from the start of vaccination to March 2022. They looked at third dose boosters 💉. They looked across all cancer types. They found 15 studies encompassing 1205 patients🧑🤝🧑. The largest global review 🌍